Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2017

Jun 5, 2017

35086_dirs_2017-06-05_d460c7b6-4baf-46b7-a1a8-d19a58a70334.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-06-01

Reporting Person: Ahlholm Frederick W (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-06-01 Common Stock M 14381 $5.19 Acquired 19381 Direct
2017-06-01 Common Stock M 7250 $4.71 Acquired 26631 Direct
2017-06-01 Common Stock S 11250 $10.00 Disposed 15381 Direct
2017-06-01 Common Stock S 10381 $11.00 Disposed 5000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-06-01 Employee Stock Option (Right to Buy) $5.19 M 14381 Disposed 2025-04-13 Common Stock (14381) Direct
2017-06-01 Employee Stock Option (Right to Buy) $4.71 M 7250 Disposed 2025-12-03 Common Stock (7250) Direct

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.

F2: This option vested as to 25% of the shares on April 14, 2016 and then in quarterly installments over 3 years thereafter.

F3: This option vested as to 25% of the shares on December 4, 2016 and then in quarterly installments over 3 years thereafter.